School of Medicine
Showing 21-40 of 263 Results
-
Keara E. Valentine
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKeara E. Valentine, Psy.D., is a clinical assistant professor at Stanford University School of Medicine in the Psychosocial Treatment Clinic and OCD Clinic, where she specializes in the assessment and treatment of OCD and related disorders. Dr. Valentine utilizes behavioral-based therapies including Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP) with children, adolescents, and adults experiencing anxiety-related disorders.
Dr. Valentine completed an APA accredited pre-doctoral internship at Alexian Brothers Behavioral Health Hospital, where she complete a rotation in OCD and anxiety disorders and a rotation in Eating Disorders. Dr. Valentine has experience working with individuals with OCD, anxiety, and/or eating disorders at various levels of care including outpatient, partial hospitalization, residential, and inpatient. -
Praveesh Valissery
Postdoctoral Scholar, Infectious Diseases
BioPraveesh was raised in Chennai, India and studied Biotechnology at the Loyola College while minoring in English Literature. He received his Ph.D. from the Jawaharlal Nehru University (New Delhi, India). He has experience in organic chemical synthesis and molecular biology. With Prof. Suman Kumar Dhar, he studied the cell cycle of the malaria parasite (Plasmodium falciparum) and worked on the optimization of water-soluble Artemisinin nanopreparations in the mouse model of malaria (Plasmodium berghei). His PhD thesis concerned “The design, discovery and improvement of novel and existing antimalarial compounds”. He helped in the synthesis and characterization of a novel class of hybrid antimalarial drug, CQ-CFX.
In the Egan lab, Praveesh is interested in exploring essential protein-protein interactions taking place at the interface between the malaria parasite and the red blood cell at key moments during invasion. His research involves the use of genome editing tools, including lentiviral and adenoviral vectors to modify hematopoietic stem cells and generate genetically modified red blood cells by ex vivo erythropoiesis.
In the long term, he hopes to
1. acquire enough skill to study and develop antimalarial vaccine antigens and improve existing vaccine formulations.
2. employ a reverse genetics approach to understand mechanisms that facilitate parasite invasion using genetically modified red blood cells. -
Adrian Valladarez
Clinical Research Coordinator Associate, Neurology
Current Role at StanfordClinical Research Coordinator Associate
-
Laura van Dam
Postdoctoral Scholar, Immunology and Rheumatology
BioI am both trained as a biomedical researcher and medical doctor in internal medicine and strive to close the gap between the clinic and fundamental sciences with translational research. My focus is to study the mechanisms of autoimmune diseases and to translate research insights into therapeutics targeting autoimmunity. I have received my PhD in 2022 in Leiden for studying neutrophil extracellular traps and autoreactive B cells in renal autoimmune diseases. My postdoctoral research project in the Robinson lab focuses on investigating the underlying molecular mechanisms of the pathogenesis of ANCA-associated vasculitis. I particularly aim to identify potential microbial triggers and molecular mimicry in ANCA-associated vasculitis, by characterizing the nasal microbiome and sequencing T cells and B cells of ANCA-associated vasculitis patients.
-
Matt van de Rijn
Sabine Kohler, MD, Professor of Pathology, Emeritus
Current Research and Scholarly InterestsOur research focuses on molecular analysis of human soft tissue tumors (sarcomas) with an emphasis on leiomyosarcoma and desmoid tumors. In addition we study the role of macrophages in range of malignant tumors.
